Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Prevalence and Prognostic Impact of Allelic Imbalances Associated with Leukemic Transformation of Philadelphia Chromosome-Negative Myeloproliferative Neoplasms.

Blood (2009) 114 (22): 1280.

https://doi.org/10.1182/blood.V114.22.1280.1280

Published: 2009

Journal Articles

The Pax5 Fusion Product Pax5-C20orf112 Causes Downregulation of Pre-B Cell Receptor Genes and Induces Differential Proliferation Patterns in B-Lymphoblastic Cell Lines.

Daniel Nowak, MD, Norihiko Kawamata, MD, PhD, Birte Niebuhr, PhD, Verena Nowak, Maximilian Mossner, Rahul R Nahar, Nils Heinrich Thoennissen, MD, Gabriela B. Iwanski, MD, Carol Stocking, PhD, Martin Dugas, MD, PhD, Wolf Karsten Hofmann, MD, PhD, Markus Müschen, MD, PhD, Phillip H Koeffler, MD, PhD

Blood (2009) 114 (22): 1284.

https://doi.org/10.1182/blood.V114.22.1284.1284

Published: 2009

Journal Articles

In Vivo Deficiency of Both Transcription Factors, C/EBPbeta and C/EBPepsilon , Results in Lack of Cytokine Response and a High Susceptibility for Overwhelming Infections.

Nils Heinrich Thoennissen, MD, Tadayuki Akagi, Jee Hoon Song, Gabriela B. Iwanski, MD, H. Phillip Koeffler, MD

Blood (2009) 114 (22): 3641.

https://doi.org/10.1182/blood.V114.22.3641.3641

Published: 2009

Journal Articles

CEBPalpha and a Critical Circadian Clock Downstream Target Gene, PER2 , Are Highly Dysregulated in Diffuse Large B-Cell Lymphoma.

Nils Heinrich Thoennissen, MD, Gabriela B. Iwanski, MD, BaoNgan Doan, Sigal Gery, PhD, Jonathan W Said, MD, H. Phillip Koeffler, MD

Blood (2009) 114 (22): 3454.

https://doi.org/10.1182/blood.V114.22.3454.3454

Published: 2009

Journal Articles

PAX5/TEL Exhibits a Dominant-Negative Role by Inhibiting the Expression of Genes Involved in BCR Signalling and Suppressing the Binding of Wild Type PAX5 to Its Direct Target Gene CD79A (mb-1) in a human Pre-B ALL Cell Line.

Gabriela B. Iwanski, MD, Nils Heinrich Thoennissen, MD, PohYeen Lor, Norihiko Kawamata, MD, PhD, Daniel Nowak, MD, Grazia Fazio, PhD, Andrea Biondi, MD, Giovanni Gazzaniga, PhD, H. Phillip Koeffler, MD

Blood (2009) 114 (22): 3455.

https://doi.org/10.1182/blood.V114.22.3455.3455

Published: 2009

Journal Articles

Expression of Circadian Core Clock Gene Per2 Is Markedly Down-Regulated in Diffuse Large B-Cell Lymphoma

Nils Heinrich Thoennissen, Qi Cao, BaoNgan Doan, Sam Abbassi, Daniel Nowak, C. Müller-Tidow, MD, Jonathan Said, MD, Sigal Gary, H. Phillip Koeffler, MD

Blood (2008) 112 (11): 4470.

https://doi.org/10.1182/blood.V112.11.4470.4470

Published: 2008

Journal Articles

Genomic Changes Associated with Leukemic Transformation of Myeloproliferative Disorders.

Nils Heinrich Thoennissen, Norihiko Kawamata, MD, Terra L Lasho, MT(ASCP), Tamara Weiss, Daniel Nowak, Motohiro Kato, Junko Takita, MD, Masashi Sanada, Torsten Haferlach, MD, Ruben A. Mesa, MD, FACP, Ayalew Tefferi, MD, C. Müller-Tidow, MD, Seishi Ogawa, MD, PhD, Phillip H Koeffler

Blood (2008) 112 (11): 3371.

https://doi.org/10.1182/blood.V112.11.3371.3371

Published: 2008

Journal Articles

ChIP-Chip in Primary AML Blasts Identifies Peroxiredoxin-II as An Epigenetically Silenced Tumor Suppressor.

Shuchi Agrawal-Singh, Markus Wiechmann, Sandra Doths, Christina Nolte, Nils Heinrich Thoennissen, Hans-Ulrich Klein, Martin Dugas, MD, Wolfgang E. Berdel, Steffen Koschmieder, MD, Hubert Serve, MD, PhD, Carsten Mueller-Tidow

Blood (2008) 112 (11): 3351.

https://doi.org/10.1182/blood.V112.11.3351.3351

Published: 2008

Journal Articles

Frequent in Vivo redundancy of C/EBPβ and C/EBPε during Myeloid Development

Nils Heinrich Thoennissen, Tadayuki Akagi, Sam Abbassi, Daniel Nowak, Ann George, Gay M. Crooks, MD, C. Müller-Tidow, MD, Adrian F Gombart, Phillip H Koeffler

Blood (2008) 112 (11): 2440.

https://doi.org/10.1182/blood.V112.11.2440.2440

Published: 2008

NARROW

Prevalence and Prognostic Impact of Allelic Imbalances Associated with Leukemic Transformation of Philadelphia Chromosome-Negative Myeloproliferative Neoplasms.

The Pax5 Fusion Product Pax5-C20orf112 Causes Downregulation of Pre-B Cell Receptor Genes and Induces Differential Proliferation Patterns in B-Lymphoblastic Cell Lines.

In Vivo Deficiency of Both Transcription Factors, C/EBPbeta and C/EBPepsilon , Results in Lack of Cytokine Response and a High Susceptibility for Overwhelming Infections.

CEBPalpha and a Critical Circadian Clock Downstream Target Gene, PER2 , Are Highly Dysregulated in Diffuse Large B-Cell Lymphoma.

PAX5/TEL Exhibits a Dominant-Negative Role by Inhibiting the Expression of Genes Involved in BCR Signalling and Suppressing the Binding of Wild Type PAX5 to Its Direct Target Gene CD79A (mb-1) in a human Pre-B ALL Cell Line.

Expression of Circadian Core Clock Gene Per2 Is Markedly Down-Regulated in Diffuse Large B-Cell Lymphoma

Genomic Changes Associated with Leukemic Transformation of Myeloproliferative Disorders.

ChIP-Chip in Primary AML Blasts Identifies Peroxiredoxin-II as An Epigenetically Silenced Tumor Suppressor.

Frequent in Vivo redundancy of C/EBPβ and C/EBPε during Myeloid Development

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only